Category Archives: News and Events

BriaCell Presents Clinical Findings at 2020 American Society of Clinical Oncology (ASCO) Meeting

Preliminary safety and efficacy data is being presented on May 29 at 9:00 a.m. ET ...

BriaCell Files Patent Application for Novel Immune Therapies for Multiple Disease Indications

BERKELEY, Calif., and VANCOUVER, British Columbia, May 20, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting

• New data and pathological findings on BriaCell’s lead candidate, Bria-IMT™, to be Highlighted at ...

BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic

• Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, for breast cancer treatment, with ...

BriaCell Files Patent Application for Novel Therapeutics for Cancer

BERKELEY, Calif., and VANCOUVER, British Columbia, April 27, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases

BERKELEY, Calif., and VANCOUVER, British Columbia, April 21, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files Coronavirus Immunotherapy Patent

BERKELEY, Calif., and VANCOUVER, British Columbia, April 14, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29

BERKELEY, Calif., and VANCOUVER, British Columbia, March 31, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Continues Clinical Operations Amidst COVID-19 Pandemic

• Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, with Incyte Corporation’s immune checkpoint ...

BriaCell to Present Clinical and Immune Activity at AACR Annual Meeting

• Clinical and immune activity of BriaCell’s lead candidate, Bria-IMT™, alone or in combination with ...